Low concentration of lipopolysaccharide acts on MC3T3-E1 osteoblasts and induces proliferation via the COX-2-independent NFkB pathway

Cell Biochemistry and Function

Volumn 27, Issue 4, 2009, Pages 238-242

  Wang, Le Yu ^a   Wang, Hai Yi ^a   Ouyang, Jun ^a   Chen, Bing ^b   Qin, Jian Qiang ^a   Qiu, Xiao Zhong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

COX 2; NFkB; Lipopolysaccharide(LPS); Osteoblasts; Proliferation

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BONE REGENERATION; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; INFLAMMATION; MC3T3 E1 CELL LINE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; TISSUE REPAIR;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; NITRILES; OSTEOBLASTS; SIGNAL TRANSDUCTION; SULFONES;

EID: 68249145922     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1563     Document Type: Article

References (24)

1. Martin TJ, Ng KW. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 1994; 56(3): 357-366.
2. Tobia PS, Gegner J, Tapping R, Orr S, Mathison J, Lee JD, Kravchenko V, Han J, Ulevitch RJ. Lipolpolysaccharide dependent cellular activation. J Periodontal Res 1997; 32 (1 Pt 2): 99-103.
3. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone destruction:mechanisms and misconceptions. Infect Immun 1996; 64(7): 2371-2380.
4. Shoji M, Tanabe N, Mitsui N, Tanaka H, Suzuki N, Takeichi O, Sugaya A, Maeno M. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts. Life Sci 2006; 78(17): 2012-2018.
5. Chung YH, Chang EJ, Kim SJ, Kim HH, Kim HM, Lee SB, Ko JS. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. J Periodontal Res 2006; 41: 288-296.
6. Huang TH, Tran VH, Duke RK, Tan S, Chrubasik S, Roufogalis BD, Duke CC. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J Ethnopharmacol 2006; 104(1-2): 149-155.
7. Woo KJ, Kwon TK. Sulforaphane suppresses lipopolysaccharide-induced cyclooxygenase-2 (COX-2) expression through the modulation of multiple targets in COX2 gene promoter. Int Immunopharmacol 2007; 7(13): 1776-1783.
8. Stevens HY, Meays DR, Yeh J, Bjursten LM, Frangos JA. COX-2 is necessary for venous ligation-mediated bone adaptation in mice. Bone 2006; 38(1): 93-104.
9. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996; 97(11): 2672-2679.
10. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of COX2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410(6827): 471-475.
11. Ackerman WE 4th, Summerfield TL, Vandre DD, Robinson JM, Kniss DA. Nuclear factor-kappa B regulates inducible prostaglandin E synthase expression in human amnion mesenchymal cells. Biol Reprod 2008; 78(1): 68-76.
12. Lu K, Liang CL, Chen HJ, et al. Nuclear factor-kappaB-regulated cyclooxygenase-2 expression in surgery-associated paraspinal muscle injury in rats. J Neurosurg 2003; 98 (2 Suppl): 181-187.
13. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18: 621-663.
14. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
15. Hong CY, Lin SK, Kok SH, et al. The role of lipopolysaccharide in infectious bone resorption of periapical lesion. J Oral Pathol Med 2004; 33(3): 162-169.
16. Bilezikian JP, Rodan GA. The Principles of Bone Biology (2nd edn). Academic Press: San Diego, 2002; 59-82.
17. Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17(6): 963-976.
18. Arasapam G, Scherer M, Cool JC, Foster BK, Xian CJ. Roles of COX-2 and iNOS in the bony repair of the injured growth plate cartilage. J Cell Biochem 2006; 99(2): 450-461.
19. Munshi N, Fernandis AZ, Cherla RP, Park IW, Ganju RK. Lipopolysaccharide-induced apoptosis of endothelial cells and its inhibition by vascular endothelial growth factor. J Immunol 2002; 168: 5860-5866.
20. Xaus J, Comalada M, Valledor AF, et al. LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 2000; 95(12): 3823-3831.
21. Feterowski C,Weighardt H, Emmanuilidis K, Hartung T, Holzmann B. Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis. Eur J Immunol 2001; 31: 1268-1277.
22. Garnier Y, Kadyrov M, Gantert M, Einig A, Rath W, Huppertz B. Proliferative responses in the placenta after endotoxin exposure in preterm fetal sheep. Eur J Obstet Gynecol Reprod Biol 2008; 138(2): 152-157.
23. Yang H, Li F, Chai J. Influence of lipopolysaccharide on the biological characteristics of skin fibroblasts and its potential role in wound healing. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2006; 20(9): 873-876.
24. Bolander ME. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992; 200(2): 165-170.